Molecular technologies for precision bioanalysis
Advanced PCR, NGS, and proteomic assay development and analysis services for bioanalysis in drug development.
Purpose-built laboratory
with the highest standards of quality, sensitivity, and regulatory compliance.
PCR technologies
High-precision assay design services using quantitative and digital PCR technologies. These highly sensitive methods enable the detection and quantification of nucleic acids, with the ability to detect low-abundant analytes in complex samples. qPCR and dPCR are widely used and accepted technologies for regulatory studies.
Next generation sequencing services
NGS technology offers high-throughput DNA and RNA sequencing for comprehensive genomic and transcriptomic analysis. With automated workflows, optimized library preparation, and market-leading NGS instruments, we tailor workflows to meet your study requirements.
Proteomic services
We run Olink and Illumina Protein Prep (IPP) services, enabling high-plex protein analysis using affinity-based proteomics (antibodies or aptamers) with only microliters of plasma or blood.
GLP and GCLP compliant laboratory
We are accredited for Good Laboratory Practice (GLP) by the Swedish Board for Accreditation and Conformity Assessment (SWEDAC) for qPCR, dPCR, and molecular biology. We are also Good Clinical Laboratory Practice (GCLP) compliant to ensure the safe and reliable analysis of clinical samples.
A purpose-built, pressure-controlled laboratory designed to maximize assay sensitivity
Compliance and quality assurance
- Fully integrated and validated LIMS
- Robust QMS
- Backups for vital systems (data storage, electricity, and instruments)
- Controlled temperature and humidity
- Comprehensive SOPs
- Skilled and qualified personnel
- Regular audits
- Transparent communication
- IT security for data integrity and protection
Instrumentation and automation
- Market-leading qPCR, dPCR, and NGS platforms.
- Automated liquid handling systems for standardized and reproducible workflows.
Resources
Overview of bioanalysis in advanced therapies
- Assay design and validation
- Regulatory guidelines (EMA and FDA)
- Challenges and best practices
Genomic biomarker analysis (DNA, RNA, miRNA, ctDNA etc,)
- Technology overview
- Analytical validation
- Regulatory overview
Capability PDF
Download our latest brochure for a summary of our molecular CRO services and capabilities.